Analyst firms · Citigroup · CAKE
Citigroup CAKE price target and rating history
Cheesecake Factory Incorporated (CAKE) · Consumer Discretionary
Citigroup rates Cheesecake Factory Incorporated (CAKE) Buy with a $47 price target, as of its latest action on May 10, 2024. It has published 3 rating actions on CAKE since April 2022, including 1 upgrade and 1 downgrade. Across 6 firms with a CAKE price target in the last 12 months, the median target is $82.50.
- Current rating
- Buy
- Price target
- $47
- Median target, all firms
- $82.50
- Actions on CAKE
- 3
Citigroup price target on CAKE
Every Citigroup rating on CAKE
- May 10, 2024
- Jan 17, 2023
- Apr 12, 2022
How other firms rate CAKE
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Jefferies | Hold | $88 | Jul 29, 2026 |
| Morgan Stanley | Equal-Weight | $80 | Jul 29, 2026 |
| Oppenheimer | Outperform | $91 | Jul 27, 2026 |
| Mizuho | Neutral | $85 | Jul 24, 2026 |
| Wells Fargo | Equal Weight | $75 | Jul 16, 2026 |
| Northcoast Research | Neutral | Jun 15, 2026 | |
| Stephens | Equal-Weight | $65 | Feb 19, 2026 |
| Raymond James | Mkt Perform | Jan 21, 2026 |
Questions about Citigroup and CAKE
- What is Citigroup's price target for CAKE?
- Citigroup's latest stated price target for Cheesecake Factory Incorporated (CAKE) is $47, from its action on May 10, 2024.
- What is Citigroup's rating on CAKE?
- Citigroup rates CAKE Buy, a bullish rating, as of May 10, 2024.
- When did Citigroup last change its view on CAKE?
- On May 10, 2024, Citigroup upgrades to Buy from Neutral, price target $38 to $47.
- How does Citigroup's CAKE target compare with other analysts?
- Across 6 firms with a CAKE price target in the last 12 months, the median target is $82.50.
More CAKE rating histories
All Citigroup ratingsCAKE news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.